The accuracy and robustness of plasma biomarker models for amyloid PET positivity

被引：0
|
作者：
Andréa L. Benedet
Wagner S. Brum
Oskar Hansson
Thomas K. Karikari
Eduardo R. Zimmer
Henrik Zetterberg
Kaj Blennow
Nicholas J. Ashton
机构：
[1] Institute of Neuroscience and Physiology,Department of Psychiatry and Neurochemistry
[2] The Sahlgrenska Academy,Translational Neuroimaging Laboratory, McGill Centre for Studies in Aging
[3] University of Gothenburg,Graduate Program in Biological Sciences: Biochemistry
[4] McGill University,Clinical Memory Research Unit, Department of Clinical Sciences
[5] Montreal,Memory Clinic
[6] Universidade Federal do Rio Grande do Sul (UFRGS),Department of Psychiatry
[7] Malmö,Department of Pharmacology
[8] Lund University,Graduate Program in Biological Sciences: Pharmacology and Therapeutics
[9] Skåne University Hospital,Clinical Neurochemistry Laboratory
[10] University of Pittsburgh,Department of Neurodegenerative Disease
[11] UFRGS,Wallenberg Centre for Molecular and Translational Medicine, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology
[12] UFRGS,undefined
[13] Sahlgrenska University Hospital,undefined
[14] UCL Institute of Neurology,undefined
[15] UK Dementia Research Institute at UCL,undefined
[16] Hong Kong Center for Neurodegenerative Diseases,undefined
[17] the Sahlgrenska Academy at the University of Gothenburg,undefined
[18] King’s College London,undefined
[19] Institute of Psychiatry,undefined
[20] Psychology & Neuroscience,undefined
[21] Maurice Wohl Clinical Neuroscience Institute,undefined
[22] NIHR Biomedical Research Centre for Mental Health & Biomedical Research Unit for Dementia at South London & Maudsley NHS Foundation,undefined
来源：
Alzheimer's Research & Therapy | / 14卷
关键词：
Amyloid; Plasma biomarker; Mass spectrometry; Immunoassay; Alzheimer’s disease; ADNI; p-tau181; GFAP; NfL;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Assessing amyloid PET positivity and cognitive function in Down syndrome to guide clinical trials targeting amyloid
    Krasny, Sophia
    Yan, Cynthia
    Hartley, Sigan L.
    Handen, Ben L.
    Wisch, Julie K.
    Boehrwinkle, Anna H.
    Ances, Beau M.
    Rafii, Michael S.
    ALZHEIMERS & DEMENTIA, 2024, 20 (08) : 5570 - 5577
  • [22] Prediction of amyloid β PET positivity using machine learning in patients with suspected cerebral amyloid angiopathy markers
    Jung, Young Hee
    Lee, Hyejoo
    Kim, Hee Jin
    Na, Duk L.
    Han, Hyun Jeong
    Jang, Hyemin
    Seo, Sang Won
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [23] Predicting amyloid PET and tau PET stages with plasma biomarkers
    Jack Jr, Clifford R.
    Wiste, Heather J.
    Algeciras-Schimnich, Alicia
    Figdore, Dan J.
    Schwarz, Christopher G.
    Lowe, Val J.
    Ramanan, Vijay K.
    Vemuri, Prashanthi
    Mielke, Michelle M.
    Knopman, David S.
    Graff-Radford, Jonathan
    Boeve, Bradley F.
    Kantarci, Kejal
    Cogswell, Petrice M.
    Senjem, Matthew L.
    Gunter, Jeffrey L.
    Therneau, Terry M.
    Petersen, Ronald C.
    BRAIN, 2023, 146 (05) : 2029 - 2044
  • [24] Sex Moderates the Impact of Diagnosis and Amyloid PET Positivity on Hippocampal Subfield Volume
    Caldwell, Jessica Z. K.
    Berg, Jody-Lynn
    Shan, Guogen
    Cummings, Jeffrey L.
    Banks, Sarah J.
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 64 (01) : 79 - 89
  • [25] Is tau in the absence of amyloid on the Alzheimer's continuum?: A study of discordant PET positivity
    Weigand, Alexandra J.
    Bangen, Katherine J.
    Thomas, Kelsey R.
    Delano-Wood, Lisa
    Gilbert, Paul E.
    Brickman, Adam M.
    Bondi, Mark W.
    BRAIN COMMUNICATIONS, 2020, 2 (01)
  • [26] Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer's amyloid, tau and FDG PET status
    Shen, Xue-Ning
    Huang, Yu-Yuan
    Chen, Shi-Dong
    Guo, Yu
    Tan, Lan
    Dong, Qiang
    Yu, Jin-Tai
    TRANSLATIONAL PSYCHIATRY, 2021, 11 (01)
  • [27] Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status
    Xue-Ning Shen
    Yu-Yuan Huang
    Shi-Dong Chen
    Yu Guo
    Lan Tan
    Qiang Dong
    Jin-Tai Yu
    Translational Psychiatry, 11
  • [28] Plasma β-amyloid:: Biomarker for Alzheimer's disease or epiphenomenon?
    Durham, R
    Lockwood, P
    Ewy, W
    Raby, C
    Evans, L
    Emmerling, M
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S384 - S385
  • [29] Novel plasma biomarker surrogating cerebral amyloid deposition
    Kaneko, Naoki
    Nakamura, Akinori
    Washimi, Yukihiko
    Kato, Takashi
    Sakurai, Takashi
    Arahata, Yutaka
    Bundo, Masahiko
    Takeda, Akinori
    Niida, Shumpei
    Ito, Kengo
    Toba, Kenji
    Tanaka, Koichi
    Yanagisawa, Katsuhiko
    PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES, 2014, 90 (09): : 353 - 364
  • [30] Establishing cutoff values for visual amyloid positivity in [18F]flutemetamol PET
    Park, Yong-Jin
    Moon, So Young
    Yoon, Joon-Kee
    Lee, Su-Jin
    An, Young-Sil
    EJNMMI RESEARCH, 2025, 15 (01):
12345